Ground News

News from Express Pharma

Your destination for news from Express Pharma. See how Express Pharma’s media bias impacts the breaking news stories of today.

We’ve aggregated 264 of Express Pharma’s headlines and news stories over the past 3 months.

Ground News rates Express Pharma’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Express Pharma

Where is Express Pharma located?Express Pharma's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Express Pharma News

HIV · United States

US FDA approves Gilead's twice-yearly injection for HIV prevention

64% Center coverage: 262 sources

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months. See the Story

Novo Nordisk · United States

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

61% Center coverage: 71 sources

Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient...See the Story

Novo Nordisk · Charleston

Long-Lasting Insulin Takes Another Step Forward with Latest Clinical Trial Results

74% Center coverage: 30 sources

On Sunday in Chicago, Dr. Athena Philis-Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute in La Jolla, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 diabetes. The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-…See the Story

Biocon's Breakthrough: Yesafili Gets Green Light in Canada

67% Left coverage: 9 sources

Biocon Biologics has received Health Canada's approval for Yesafili, a biosimilar injection for eye ailments. As the first Eylea biosimilar approved in Canada, Yesafili's launch is set for July 4, 2025. This milestone highlights Biocon's commitment to affordable, high-quality biologics worldwide.Health Canada · Toronto See the Story

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Coverage: 6 sources

The collaboration, supported by Gavi and WHO, aims to protect at least 50 million more children in Africa from malaria by 2030Vaccinations · India See the Story

Diagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during 2024-34, forecasts GlobalData - Express Pharma

The diagnosed prevalent cases of multiple sclerosis (MS) in the seven major markets (7MM*) are projected to increase from 1.61 million in 2024 to 1.64 million in 2034 at an annual growth rate (AGR) of negative 0.19 per cent, forecasts GlobalData. GlobalData’s latest report, “Multiple Sclerosis Epidemiology Analysis and Forecast to 2034,” reveals that in 2034, the US is forecasted to experience the greatest number of diagnosed prevalent cases of …United States · United States Read Article

Punjab Government and Ananya Birla Foundation launch DITSU to strengthen drug abuse response - Express Pharma

The Government of Punjab has launched the Data Intelligence and Technical Support Unit (DITSU) as part of its Yudh Nasheyan Virudh campaign to address drug and substance abuse in the state. The initiative marks a public-private collaboration with the Ananya Birla Foundation (ABF) and aims to strengthen systemic, data-driven responses to drug-related issues. The launch was formalised through a Memorandum of Understanding signed by Bhagwant Mann, …Chandigarh, Sangrur, India · Chandigarh Read Article

Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26 - Express Pharma

Kashmik Formulation, a pharma manufacturing firm based in Ahmedabad, has announced plans to expand its production capacity, increase automation, and enhance its international footprint. The company has set a revenue target of ₹100 crore for the financial year 2025–26, following a 100 per cent year-on-year growth from ₹20 crore in FY23–24 to ₹40 crore in FY24–25. Currently operating at full capacity, Kashmik Formulation produces one crore tablets…Ahmedabad · Ahmedabad Read Article

Lupin launches Prucalopride Tablets in the US market post FDA approval - Express Pharma

Global pharma major Lupin today announced the launch of Prucalopride Tablets, 1 mg, and 2 mg, in the United States, following the recent approval of its Abbreviated New Drug Application (ANDA) from the U.S. FDA. Prucalopride Tablets are bioequivalent to Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals U.S.A. Inc., and indicated for the treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride Tablets, 1 mg, and 2 mg (…United States · United States Read Article

New guidance helps GPs manage patients using weight loss drugs

Coverage: 2 sources

Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs.NHS · London See the Story

Gujarat-Based Sudeep Pharma Limited Files DRHP for IPO

Gujarat-based Sudeep Pharma, a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries, has filed its draft red herring prospectus (DRHP) with capital market regulator Securities and Exchange Board of India (SEBI) to mop up funds through an initial public offering (IPO). The IPO, with a face value of ₹1 each, combines fresh issuance […] The post Gujarat-based Sudeep Pharma Limite…IPO · Gujarat See the Story

News from Express Pharma

News from Express Pharma

Information about Express Pharma

Media Bias Ratings

Factuality

Ownership

Top Express Pharma News

US FDA approves Gilead's twice-yearly injection for HIV prevention

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

Long-Lasting Insulin Takes Another Step Forward with Latest Clinical Trial Results

Biocon's Breakthrough: Yesafili Gets Green Light in Canada

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Diagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during 2024-34, forecasts GlobalData - Express Pharma

Punjab Government and Ananya Birla Foundation launch DITSU to strengthen drug abuse response - Express Pharma

Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26 - Express Pharma

Lupin launches Prucalopride Tablets in the US market post FDA approval - Express Pharma

New guidance helps GPs manage patients using weight loss drugs

Gujarat-Based Sudeep Pharma Limited Files DRHP for IPO

Similar News Topics

Topics Most Covered by Express Pharma

Sources Covering Similar Topics

Breaking News Topics Related to Express Pharma